Profile data is unavailable for this security.
About the company
Qingdao NovelBeam Technology Co Ltd is a China-based company principally engaged in the research and development, production and sales of medical endoscopic equipment and optical products. Its main products of medical endoscope equipment include fluorescent endoscopes, fluorescent camera adapters/adaptive lenses, fluorescent light source modules and white light source modules. Its medical endoscopic equipment products are mainly used in abdominal endoscopic surgery such as liver and gallbladder and gastrointestinal surgery. Its optical products mainly include medical optical products, industrial and laser optical products, and biometric products. Among them, the biometric products include fingerprint devices, palmprint devices and related accessories. In addition, the Company also provides technical services and house leasing services. The Company distributes its products both in the domestic market and to overseas markets.
- Revenue in CNY (TTM)439.81m
- Net income in CNY135.69m
- Incorporated2003
- Employees797.00
- LocationQingdao NovelBeam Technology Co LtdNo.100 Keyuanwei 4th RoadLaoshan DistrictQINGDAO 266100ChinaCHN
- Phone+86 53 288706015
- Fax+86 53 288705263
- Websitehttps://www.novelbeam.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai Sanyou Medical Co Ltd | 385.98m | 58.83m | 4.50bn | 466.00 | 79.50 | 2.35 | -- | 11.67 | 0.228 | 0.228 | 1.53 | 7.71 | 0.1699 | 0.5891 | 2.20 | 828,288.80 | 3.29 | 9.42 | 3.86 | 10.85 | 71.52 | 87.15 | 19.34 | 29.78 | 3.35 | -- | 0.0291 | 16.21 | -29.08 | 15.67 | -49.91 | 8.99 | -15.60 | -- |
| Hubei Huaqiang High-Tech Co Ltd | 502.24m | 4.95m | 4.51bn | 706.00 | 910.23 | 1.08 | -- | 8.97 | 0.0144 | 0.0144 | 1.46 | 12.15 | 0.0993 | 1.83 | 0.7415 | 711,388.30 | 0.0978 | 3.82 | 0.1078 | 4.62 | 11.73 | 26.28 | 0.9853 | 14.29 | 7.84 | -- | 0.0043 | 20.55 | -2.21 | -5.08 | -88.36 | -40.15 | -12.17 | -- |
| SWS Hemodialysis Care Co Ltd | 659.16m | 154.15m | 4.57bn | 881.00 | 29.66 | 2.66 | -- | 6.94 | 0.7148 | 0.7148 | 3.06 | 7.97 | 0.3351 | 2.11 | 5.56 | 748,197.70 | 7.71 | -- | 8.68 | -- | 50.81 | -- | 23.00 | -- | 15.96 | -- | 0.0089 | -- | 80.65 | -- | 228.34 | -- | -- | -- |
| Hangzhou Ags Medtech Co Ltd | 529.86m | 235.79m | 4.70bn | 592.00 | 19.95 | 2.09 | -- | 8.88 | 4.07 | 4.07 | 9.16 | 38.92 | 0.3775 | 3.36 | 13.43 | 895,039.90 | 16.80 | -- | 17.73 | -- | 70.24 | -- | 44.50 | -- | 24.45 | -- | 0.0054 | -- | 37.09 | -- | 49.87 | -- | -- | -- |
| Zhejiang Gongdong Medical Techno Co Ltd | 1.02bn | 125.32m | 5.04bn | 1.67k | 40.13 | 2.99 | -- | 4.93 | 1.11 | 1.11 | 9.07 | 14.98 | 0.5447 | 6.00 | 4.59 | 609,805.40 | 6.69 | 16.35 | 7.46 | 19.26 | 31.13 | 41.19 | 12.28 | 21.62 | 3.85 | -- | 0.0201 | 38.99 | -33.61 | 15.11 | -66.53 | 5.14 | 27.71 | -- |
| Qingdao NovelBeam Technology Co Ltd | 439.81m | 135.69m | 5.07bn | 797.00 | 37.20 | 3.80 | -- | 11.52 | 1.12 | 1.12 | 3.62 | 10.95 | 0.3138 | 1.08 | 4.50 | 551,832.80 | 9.45 | 14.67 | 10.07 | 16.63 | 62.54 | 62.32 | 30.11 | 34.15 | 11.88 | -- | 0.0039 | 33.55 | -1.31 | 18.58 | -20.19 | 21.71 | 10.45 | -- |
| Xiangyu Medical Co Ltd | 770.75m | 227.62m | 5.37bn | 1.82k | 23.17 | 2.54 | -- | 6.96 | 1.45 | 1.45 | 4.90 | 13.23 | 0.2968 | 1.08 | 18.95 | 423,724.10 | 8.80 | 11.18 | 10.79 | 13.12 | 67.66 | 66.78 | 29.64 | 32.69 | 1.89 | -- | 0.1247 | 27.33 | 52.46 | 15.72 | 81.03 | 23.11 | 132.76 | -- |
| Zhende Medical Co Ltd | 3.79bn | 125.34m | 5.42bn | 6.72k | 43.02 | 0.986 | -- | 1.43 | 0.4728 | 0.4728 | 14.30 | 20.63 | 0.4702 | 2.96 | 5.83 | 564,307.70 | 1.74 | 17.13 | 2.16 | 23.54 | 33.65 | 38.05 | 3.71 | 17.33 | 1.88 | -- | 0.1884 | 29.85 | -32.76 | 23.63 | -70.87 | 8.79 | 21.46 | 47.58 |
| Holder | Shares | % Held |
|---|---|---|
| Orient Securities Asset Management Co. Ltd.as of 31 Dec 2023 | 5.70m | 7.58% |
| Da Cheng Fund Management Co., Ltd.as of 31 Dec 2023 | 3.47m | 4.61% |
| New China Fund Management Co., Ltd.as of 31 Dec 2023 | 3.04m | 4.04% |
| China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 1.87m | 2.49% |
| ABC-CA Fund Management Co., Ltd.as of 31 Dec 2023 | 1.46m | 1.94% |
| Truvalue Asset Management Co. Ltd.as of 31 Dec 2023 | 1.18m | 1.57% |
| Cinda Fund Management Co. Ltd.as of 31 Dec 2023 | 1.01m | 1.35% |
| Yinhua Fund Management Co., Ltd.as of 31 Dec 2023 | 813.70k | 1.08% |
| JPMorgan Asset Management (China) Co Ltd.as of 31 Dec 2023 | 744.56k | 0.99% |
| Aegon-Industrial Fund Management Co., Ltd.as of 31 Dec 2023 | 718.06k | 0.96% |
